microRNAs: Novel Markers in Diagnostics and Therapeutics of Celiac Disease.
celiac diseases
microRNA
personalized medicine
Journal
DNA and cell biology
ISSN: 1557-7430
Titre abrégé: DNA Cell Biol
Pays: United States
ID NLM: 9004522
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
pubmed:
14
5
2019
medline:
20
7
2019
entrez:
14
5
2019
Statut:
ppublish
Résumé
microRNAs (miRNAs) are a novel class of single-stranded RNAs with a key role in the regulation of gene expression. miRNA main mechanism of action involves interaction with the mRNA transcribed from the genes, leading to the target mRNA silencing and degradation. Indeed, it is easy to conceive that a defective miRNA-based mRNA regulation may compromise normal cell function and cause genetic diseases. A wide spectrum of studies has focused on the identification and introduction of regulatory diseases-specific miRNAs for the past decade. Overexpression or downregulation of several miRNAs can potentially stimulate or inhibit pathways related to the pathogenesis of celiac disease (CD). CD is a chronic inflammatory disease characterized by small intestinal mucosal injury and nutrient malabsorption in genetically susceptible individuals after the dietary ingestion of gluten. The disease is characterized by villous atrophy, intraepithelial lymphocyte infiltration, and chronic inflammation and activation of lamina propria T cells. The common genetic background in CD is the presence of heterodimeric human leukocyte antigen class II molecules
Identifiants
pubmed: 31081687
doi: 10.1089/dna.2018.4561
doi:
Substances chimiques
Biomarkers
0
HLA-DQ Antigens
0
HLA-DQ2 antigen
0
MicroRNAs
0
Glutens
8002-80-0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM